Stockscreener 앱 받기
31.17
8.89%
-3.15
Longboard Pharmaceuticals Inc 주식(LBPH)의 최신 뉴스
When the Price of (LBPH) Talks, People Listen - Stock Traders Daily
Check out these key findings about Longboard Pharmaceuticals Inc (LBPH) - SETE News
Daily Market Movement: Longboard Pharmaceuticals Inc (LBPH) Sees a -0.98 Decrease, Closing at 33.27 - The Dwinnex
Ratio Analysis: Unpacking Longboard Pharmaceuticals Inc (LBPH)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
LBPH’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
LBPH underperforms with a -4.90 decrease in share price - US Post News
TD Asset Management Inc Buys 33,400 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
TD Asset Management Inc Boosts Stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Longboard Pharmaceuticals (NASDAQ:LBPH) Receives New Coverage from Analysts at Truist Financial - Defense World
Truist sets stock price target on Longboard Pharma with Buy rating - Investing.com
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $34.51 - MarketBeat
Longboard Pharmaceuticals Boasts Valuable Epilepsy Drugs: AnalystLongboard Pharmaceuticals (NASDAQ:LBPH) - Benzinga
Truist Financial Begins Coverage on Longboard Pharmaceuticals (NASDAQ:LBPH) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Makes New $127,000 Investment in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Emerald Advisers LLC Makes New Investment in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Baird reaffirms confidence in Longboard stock after positive OLE data update - Investing.com
Candriam S.C.A. Makes New Investment in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Longboard reports interim data from Phase II extension trial of DEEs treatment - Yahoo Finance
Emerald Mutual Fund Advisers Trust Invests $4.96 Million in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs) - Business Wire
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Receives Consensus Rating of “Buy” from Analysts - Defense World
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Baird keeps Outperform on Longboard shares ahead of upcoming investor event By Investing.com - Investing.com India
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Up 2.5% - MarketBeat
Baird keeps Outperform on Longboard shares ahead of upcoming investor event By Investing.com - Investing.com Canada
CMO Kaye Randall acquire 100 shares of Longboard Pharmaceuticals Inc [LBPH] - Knox Daily
Examining Longboard Pharmaceuticals Inc (LBPH) stock is warranted - US Post News
How To Trade (LBPH) - Stock Traders Daily
Longboard Pharmaceuticals to Participate in Four Upcoming Investor Conferences in September - Business Wire
Longboard Pharmaceuticals to Participate in Four Upcoming Investor Conferences in September - The Bakersfield Californian
Longboard Pharmaceuticals Inc (LBPH) may enjoy gains as insiders got busy in the recent days - Knox Daily
A stock that deserves closer examination: Longboard Pharmaceuticals Inc (LBPH) - US Post News
My Strategy For Longboard Pharmaceuticals After Its Big Run - Seeking Alpha
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Down 5.4% - MarketBeat
LBPH’s Stock Dilemma: Longboard Pharmaceuticals Inc’s Market Performance and Outlook - The InvestChronicle
Deeper Dive: Understanding Longboard Pharmaceuticals Inc (LBPH) Through its Various Ratios - The Dwinnex
Longboard Pharmaceuticals to Host Investor and Analyst Event in New York on September 16, 2024 - Marketscreener.com
Longboard Pharmaceuticals (NASDAQ:LBPH) Receives Outperform Rating from Evercore ISI - Defense World
Longboard Pharmaceuticals (NASDAQ:LBPH) Stock Price Up 4.3% - MarketBeat
Longboard Pharmaceuticals to Present Late-Breaking and Encore Data at the 15th European Epilepsy Congress - Business Wire
LBPHLongboard Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Longboard Pharmaceuticals (NASDAQ:LBPH) Rating Reiterated by Evercore ISI - MarketBeat
Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on September 16, 2024 - Business Wire
HC Wainwright Weighs in on Longboard Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:LBPH) - MarketBeat
Q3 2024 Earnings Forecast for Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Issued By HC Wainwright - Defense World
Was anything negative for Longboard Pharmaceuticals Inc (LBPH) stock last session? - US Post News
Longboard Pharmaceuticals (NASDAQ:LBPH) Trading Down 3.5% - Defense World
HC Wainwright Reaffirms “Buy” Rating for Longboard Pharmaceuticals (NASDAQ:LBPH) - Defense World
Market Momentum: Longboard Pharmaceuticals Inc (LBPH) Registers a 3.98 Increase, Closing at 35.75 - The Dwinnex
HC Wainwright Reaffirms "Buy" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH) - MarketBeat
Longboard Pharmaceuticals Inc [LBPH] CMO makes an insider purchase of 100 shares worth 2482.0. - Knox Daily
Longboard Pharmaceuticals (NASDAQ:LBPH) Stock Price Down 3.5% - MarketBeat
Short Interest in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Grows By 11.0% - American Banking and Market News
California State Teachers Retirement System Has $470,000 Stock Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Short Interest in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Increases By 11.0% - MarketBeat
Longboard Pharmaceuticals CMO buys shares, sells for $578,804 By Investing.com - Investing.com Australia
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) CMO Randall Kaye Sells 16,667 Shares of Stock - Defense World
Longboard Pharmaceuticals CMO buys shares, sells for $578,804 - Investing.com
Analysts Set Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) PT at $57.13 - MarketBeat
Longboard Pharmaceuticals CMO buys shares, sells for $578,804 By Investing.com - Investing.com Canada
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) CMO Randall Kaye Sells 16,667 Shares - MarketBeat
Longboard Pharmaceuticals CMO buys shares, sells for $578,804 By Investing.com - Investing.com UK
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Down 7.8% - Defense World
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Down 7.8% - MarketBeat
1.26%
1.94%
자본화:
|
볼륨(24시간):